HSBC Holdings’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
159,300
-267,600
-63% -$18.6M 0.01% 931
2025
Q4
$28.4M Sell
426,900
-58,900
-12% -$3.81M 0.01% 646
2025
Q3
$32.5M Buy
485,800
+176,300
+57% +$14M 0.02% 585
2025
Q2
$26.9M Sell
309,500
-12,600
-4% -$988K 0.02% 618
2025
Q1
$21.7M Buy
322,100
+170,900
+113% +$13.9M 0.01% 684
2024
Q4
$11.8M Sell
151,200
-25,900
-15% -$1.92M 0.01% 886
2024
Q3
$11.9M Sell
177,100
-104,900
-37% -$8.61M 0.01% 874
2024
Q2
$31.8M Buy
282,000
+238,800
+553% +$30.2M 0.02% 560
2024
Q1
$5.99M Sell
43,200
-53,700
-55% -$6.75M ﹤0.01% 1034
2023
Q4
$12.1M Sell
96,900
-48,200
-33% -$4.92M 0.01% 826
2023
Q3
$13.6M Buy
145,100
+66,700
+85% +$7.52M 0.01% 735
2023
Q2
$10.1M Buy
+78,400
New +$9.48M 0.01% 814

Other funds holding DXCM

HSBC Holdings's DXCM Position: Q1 2026 in Review

HSBC Holdings increased its DexCom (DXCM) stake by 32% in Q1 2026, buying an estimated $19.5M and bringing the position to 1,166,543 shares worth $73.4M. The position accounts for 0.04% of the portfolio, ranked #407.

HSBC Holdings first reported a position in DXCM in Q1 2015 and has held it in 45 quarters since. The position peaked at $143M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • HSBC Holdings held 1,166,543 shares of DexCom worth $73.4M as of Q1 2026.
  • HSBC Holdings bought 280,259 DexCom shares in Q1 2026, an estimated $19.5M.
  • DexCom made up 0.04% of HSBC Holdings's portfolio in Q1 2026, its #407 holding.
  • HSBC Holdings first reported a position in DexCom in Q1 2015 and has held it in 45 quarters since.
  • HSBC Holdings's DexCom position peaked at $143M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.